CEO’s Message
Comprehensive Support Covering All Aspects from Talent Development to Field-Level Operations
Our world is constantly changing with the advancements in healthcare. Particularly in pharmaceutical development, we have witnessed remarkable evolution from chemicals to biologics and further to regenerative and cell therapies. CUES Consulting stands behind our clients at the forefront of these dynamic changes, contributing to the growth of the healthcare industry.
We offer a wide range of services, including development regulatory affairs, pharmaceutical regulation, CMC regulatory affairs, Pharmacovigilance, and post-marketing surveillance. All these services are supported by professionals with extensive experience in the pharmaceutical industry. Our expertise and experience are utilized to fully support our clients from the development of pharmaceuticals to their market introduction.
CUES Consulting aspires not just to follow the changes in the medical industry but to be a leader in these changes. Our mission is to provide new hope and treatment opportunities to patients through innovative medical solutions. We are committed to our daily operations with this purpose in mind.
Representative Director of CUES Consulting Inc.
Motoyuki Takano
Introduction of Consultants
Motoyuki Takano
Representative Director, CUES Consulting Inc.
Specialization
- Streamlining pharmacovigilance organizations
- Planning safety assurance measures
- Transferring safety data at the time of succession
- Creating risk management plans
- Planning global safety measures
Career History
- Daiichi Pharmaceuticals: Sales Planning, Clinical Development Project Leader
- Wyeth: Clinical Development Project Leader
- Sanofi: Clinical Development Project Leader, PV Database Management
- Shire: Head of Pharmacovigilance, Safety Manager
- Ferring: Head of Pharmacovigilance, Safety Manager, Post-Marketing Surveillance Manager
- Medtronic: Head of Clinical Trial Safety Management, Safety Manager
![](https://cues.or.jp/cms/wp-content/uploads/2024/04/img01.jpg)
Takashi Yoshida
Chairman of CUES Consulting Inc.
Specialization
- Regulatory affairs strategy (development, post-marketing regulatory affairs)
- Corporate risk management
- Mergers and acquisitions, product succession
Career History
- Fujisawa Pharmaceutical Co., Ltd.: Clinical development, Head of Development Regulatory Affairs, US Project Management
- Astellas Pharma Inc.: Head of Development Regulatory Affairs
- Sanofi: Executive Officer, Head of Regulatory Affairs, Head of Pharmacovigilance, Head of Reliability Assurance, Head of Regulatory Affairs for Japan-Pacific Region, Overall Manufacturing and Marketing Manager
- GlaxoSmithKline: Director of Regulatory Affairs, Head of Public Affairs, Overall Manufacturing and Marketing Manager
![](https://cues.or.jp/cms/wp-content/uploads/2024/04/img02.jpg)
Specialized Consultants / Career Backgrounds
Collaboration with External Companies
Domestic medical writing company (CTD document preparation), drug pricing consulting firm (Drug pricing strategy planning for pharmaceuticals, medical devices, regenerative medicine products, drug pricing application preparation, drug pricing negotiation representation), electronic application document preparation company (CDISC, Gateway compliance), etc.